These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 17044028

  • 1. Different structural components of conventional papillary thyroid carcinoma display mostly identical BRAF status.
    Abrosimov A, Saenko V, Rogounovitch T, Namba H, Lushnikov E, Mitsutake N, Yamashita S.
    Int J Cancer; 2007 Jan 01; 120(1):196-200. PubMed ID: 17044028
    [Abstract] [Full Text] [Related]

  • 2. BRAF mutations are associated with some histological types of papillary thyroid carcinoma.
    Trovisco V, Vieira de Castro I, Soares P, Máximo V, Silva P, Magalhães J, Abrosimov A, Guiu XM, Sobrinho-Simões M.
    J Pathol; 2004 Feb 01; 202(2):247-51. PubMed ID: 14743508
    [Abstract] [Full Text] [Related]

  • 3. High prevalence and possible de novo formation of BRAF mutation in metastasized papillary thyroid cancer in lymph nodes.
    Vasko V, Hu S, Wu G, Xing JC, Larin A, Savchenko V, Trink B, Xing M.
    J Clin Endocrinol Metab; 2005 Sep 01; 90(9):5265-9. PubMed ID: 15998781
    [Abstract] [Full Text] [Related]

  • 4. Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients' age but not with tumour aggressiveness.
    Trovisco V, Soares P, Preto A, de Castro IV, Lima J, Castro P, Máximo V, Botelho T, Moreira S, Meireles AM, Magalhães J, Abrosimov A, Cameselle-Teijeiro J, Sobrinho-Simões M.
    Virchows Arch; 2005 Jun 01; 446(6):589-95. PubMed ID: 15902486
    [Abstract] [Full Text] [Related]

  • 5. The role of molecular markers and tumor histological type in central lymph node metastasis of papillary thyroid carcinoma.
    Paulson L, Shindo M, Schuff K, Corless C.
    Arch Otolaryngol Head Neck Surg; 2012 Jan 01; 138(1):44-9. PubMed ID: 22249628
    [Abstract] [Full Text] [Related]

  • 6. Mutant BRAF(T1799A) can be detected in the blood of papillary thyroid carcinoma patients and correlates with disease status.
    Cradic KW, Milosevic D, Rosenberg AM, Erickson LA, McIver B, Grebe SK.
    J Clin Endocrinol Metab; 2009 Dec 01; 94(12):5001-9. PubMed ID: 19850689
    [Abstract] [Full Text] [Related]

  • 7. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM, Ding HG, Gattuso P, Prinz RA, Xu X.
    Cancer; 2005 Jun 01; 103(11):2261-8. PubMed ID: 15880523
    [Abstract] [Full Text] [Related]

  • 8. Detectable BRAF mutation in serum DNA samples from patients with papillary thyroid carcinomas.
    Chuang TC, Chuang AY, Poeta L, Koch WM, Califano JA, Tufano RP.
    Head Neck; 2010 Feb 01; 32(2):229-34. PubMed ID: 19626635
    [Abstract] [Full Text] [Related]

  • 9. The heterogeneous distribution of BRAF mutation supports the independent clonal origin of distinct tumor foci in multifocal papillary thyroid carcinoma.
    Giannini R, Ugolini C, Lupi C, Proietti A, Elisei R, Salvatore G, Berti P, Materazzi G, Miccoli P, Santoro M, Basolo F.
    J Clin Endocrinol Metab; 2007 Sep 01; 92(9):3511-6. PubMed ID: 17535994
    [Abstract] [Full Text] [Related]

  • 10. Follicular variant of papillary thyroid carcinoma (FVPTC): histological features, BRAF V600E mutation, and lymph node status.
    Walts AE, Mirocha JM, Bose S.
    J Cancer Res Clin Oncol; 2015 Oct 01; 141(10):1749-56. PubMed ID: 25702102
    [Abstract] [Full Text] [Related]

  • 11. A new BRAF gene mutation detected in a case of a solid variant of papillary thyroid carcinoma.
    Trovisco V, Soares P, Soares R, Magalhães J, Sá-Couto P, Sobrinho-Simões M.
    Hum Pathol; 2005 Jun 01; 36(6):694-7. PubMed ID: 16021577
    [Abstract] [Full Text] [Related]

  • 12. Prediction of occult central lymph node metastasis in papillary thyroid carcinoma by preoperative BRAF analysis using fine-needle aspiration biopsy: a prospective study.
    Joo JY, Park JY, Yoon YH, Choi B, Kim JM, Jo YS, Shong M, Koo BS.
    J Clin Endocrinol Metab; 2012 Nov 01; 97(11):3996-4003. PubMed ID: 22930785
    [Abstract] [Full Text] [Related]

  • 13. Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.
    Cañadas-Garre M, Becerra-Massare P, López de la Torre-Casares M, Villar-del Moral J, Céspedes-Mas S, Vílchez-Joya R, Muros-de Fuentes T, García-Calvente C, Piédrola-Maroto G, López-Nevot MA, Montes-Ramírez R, Llamas-Elvira JM.
    Ann Surg; 2012 May 01; 255(5):986-92. PubMed ID: 22504197
    [Abstract] [Full Text] [Related]

  • 14. BRAF and RAS Mutational Status in Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features and Invasive Subtype of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma in Korea.
    Kim M, Jeon MJ, Oh HS, Park S, Kim TY, Shong YK, Kim WB, Kim K, Kim WG, Song DE.
    Thyroid; 2018 Apr 01; 28(4):504-510. PubMed ID: 29439609
    [Abstract] [Full Text] [Related]

  • 15. BRAF mutation detection in indeterminate thyroid cytology specimens: underlying cytologic, molecular, and pathologic characteristics of papillary thyroid carcinoma.
    Ohori NP, Singhal R, Nikiforova MN, Yip L, Schoedel KE, Coyne C, McCoy KL, LeBeau SO, Hodak SP, Carty SE, Nikiforov YE.
    Cancer Cytopathol; 2013 Apr 01; 121(4):197-205. PubMed ID: 22887810
    [Abstract] [Full Text] [Related]

  • 16. Clinicopathologic implications of the BRAF(V600E) mutation in papillary thyroid cancer: a subgroup analysis of 3130 cases in a single center.
    Lim JY, Hong SW, Lee YS, Kim BW, Park CS, Chang HS, Cho JY.
    Thyroid; 2013 Nov 01; 23(11):1423-30. PubMed ID: 23496275
    [Abstract] [Full Text] [Related]

  • 17. Correlation between BRAF mutation and the clinicopathological parameters in papillary thyroid carcinoma with particular reference to follicular variant.
    Smith RA, Salajegheh A, Weinstein S, Nassiri M, Lam AK.
    Hum Pathol; 2011 Apr 01; 42(4):500-6. PubMed ID: 21167555
    [Abstract] [Full Text] [Related]

  • 18. [An investigation of BRAF mutation in papillary thyroid carcinoma and its clinical value].
    Gong RX, Zhou Y, Luo SH, Zhang L, Zhou B.
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Jun 01; 26(3):310-3. PubMed ID: 19504446
    [Abstract] [Full Text] [Related]

  • 19. BRAF mutations in an Italian cohort of thyroid cancers.
    Fugazzola L, Mannavola D, Cirello V, Vannucchi G, Muzza M, Vicentini L, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2004 Aug 01; 61(2):239-43. PubMed ID: 15272920
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.